Navigation Links
Frost & Sullivan: Asia Pacific Infectious Disease Diagnostics Market Grows as Economies Boom and Countries Become Image Conscious

SINGAPORE, Aug. 13, 2012 /PRNewswire/ -- The occurrence of infectious diseases – vector and blood borne – is high in Asia Pacific countries due to the tropical climate. While limited healthcare budgets had prevented most countries in the region from investing on diagnosis, treatment and elimination protocols, improving economies as well as funding and grants from international organizations have seen the adoption of earlier diagnosis and treatment strategies in recent years.

New analysis from Frost & Sullivan (, Asia Pacific Infectious Disease Diagnostics Market, expects the market to grow at 13.2 percent to reach revenues of $3,063.2 million by 2016. The study analyses the immunochemistry, molecular diagnostics and microbiology markets for the treatment of malaria, dengue, tuberculosis, HIV, hepatitis C, STI, influenza and pertussis.

As Asian countries position themselves as a popular medical tourism destination, the need to control incidences of infectious disease is considered a priority. Hence these countries are focusing on ways to improve diagnosis of diseases in high risk endemic areas.

"Vector borne diseases such as dengue and malaria were prevalent only in developing and emerging economies in Asia; however, blood borne diseases like HIV and Hepatitis are an issue in most of the Asia Pacific countries," says Frost & Sullivan Consultant Poornima Srinivasan. "Elimination strategies and national diagnosis policies focusing on microbiology testing and molecular testing are gaining grounds and these countries aim to be free from infectious disease by 2030."

The number of private hospitals and stand alone laboratories are expected to rise with ageing population and increased incidence of infectious disease. These factors drive the need for infectious disease diagnostic testing using sophisticated technologies.

Since the infectious disease diagnostics market is technology and price driven in most Asia Pacific countries, competitive pricing and relationship with distributors are the way forward for vendors in the market.

"Most countries are expected to adapt molecular diagnostic testing for blood borne infectious disease," opines Srinivasan. "It is likely that with huge research and development investments, multinational companies will continue to dominate the market after making an early entry in the molecular diagnostic segments for infectious diseases."

If you are interested in more information on this study, please send an e-mail with your contact details to Jessie Loh, Corporate Communications, at You can register for the pre-recorded Analyst Briefing by clicking on the following link:

For a virtual brochure of this study, go to:

Asia Pacific Infectious Disease Diagnostics Market is part of the Clinical Diagnostics Growth Partnership Services program. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation


Donna Jeremiah
Corporate Communications –  Asia Pacific
P: + 61 (02) 8247 8927
F: +61 (02) 9252 8066 

Jessie Loh
Corporate Communications – Asia Pacific
P: +65 6890 0942

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
2. Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria
3. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
4. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
7. Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market
8. Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon
9. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
10. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
11. Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
Post Your Comments:
(Date:11/25/2015)... 2015 2 nouvelles études permettent d ... les différences entre les souches bactériennes retrouvées dans la plaque ... êtres humains . Ces recherches  ouvrent une nouvelle ... en charge efficace de l,un des problèmes de ... .    --> 2 nouvelles études permettent ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
Breaking Biology Technology:
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):